Sartorius
Sartorius is a renowned supplier of laboratory equipment and services, dedicated to providing high-quality solutions for researchers, laboratories, and biopharmaceutical manufacturers. With a commitment to excellence, Sartorius supports scientific endeavors by delivering reliable instruments and consumables, contributing to advancements in research and bioprocessing.Content by Sartorius
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
Pharmaceutical microbiology quality control monitoring and bioburden testing
| 1 min read
False negative test results are, by far, worse than any false positive test results
| 1 min read
When testing for advanced therapy medicinal products or ATMPs, time is critical
| 1 min read
Know what class-leading features to look for, so your balance offers maximum versatility and value
| 1 min read
Accuracy, repeatability, and versatility deliver maximum value for the laboratory now, and into the future
| 1 min read
With three different models to choose from, users can strike the right balance between throughput needs and budget
| 2 min read
Implement robust quality control procedures to reduce risks for product integrity and safety
| 1 min read
Protect your experiments by understanding microbiological quality control
| 1 min read
Prevent chemical compounds from inhibiting cell-based, biochemical, and biological assays
| 1 min read
Continuous air monitoring, isokinetic sampling, and the advantages of gelatine filters
| 1 min read
Learn how Sartorius and Abbott Informatics developed a complete computerized solution for a professional integration of Sartorius Cubis ® II balances into STARLIMS™ covering all cGMP/cGLP aspects
| 1 min read
Learn how the Cubis® II meets the requirements of the pharmaceutical industry
| 1 min read
Learn about groundbreaking solutions to advance therapeutic peptide development
| 1 min read
Powerful platforms for candidate identification, and insights into
cellular effects and biomolecular interactions
| 4 min read
